汉森制药：中药新药苁蓉颗粒正处于工艺中试放大研究阶段

Group 1 - The company is currently in the process of scaling up the production of its new traditional Chinese medicine product, Cangrong Granules, which is in the pilot testing phase [1] - The Tianma Xingnao Capsule is designed to nourish the liver and kidneys, alleviate pain, and is used for symptoms related to liver and kidney deficiency, such as headaches, dizziness, memory decline, insomnia, sluggishness, tinnitus, and lower back pain [1] - For detailed information, the company refers investors to its 2024 annual report [1]